CFAP299
gene geneOn this page
Summary
CFAP299 (cilia and flagella associated protein 299, HGNC:28554) is a protein-coding gene on chromosome 4q21.21, encoding Cilia- and flagella-associated protein 299 (Q6V702). May be involved in spermatogenesis.
Predicted to be located in cytoplasm.
Source: NCBI Gene 255119 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 15
- Clinical variants (ClinVar): 15 total
- GTEx eGene: eQTL in 8 tissues, sQTL in 3 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.36 (unconstrained)
- MANE Select transcript:
NM_152770
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28554 |
| Approved symbol | CFAP299 |
| Name | cilia and flagella associated protein 299 |
| Location | 4q21.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000197826 |
| Ensembl biotype | protein_coding |
| Entrez | 255119 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 protein_coding_CDS_not_defined, 2 protein_coding, 2 nonsense_mediated_decay
MANE Select: ENST00000358105
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 2, TSL 2: 2, TSL 3: 3, TSL 5: 1
ENST00000358105, ENST00000502497, ENST00000503883, ENST00000508314, ENST00000508675, ENST00000512931, ENST00000513920, ENST00000514249
RefSeq mRNA: 2 — MANE Select: NM_152770
NM_001206997, NM_152770
CCDS: CCDS3587, CCDS56336
Canonical transcript exons
ENST00000358105 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001410586 | 80944810 | 80944939 |
| ENSE00001415278 | 80963517 | 80963750 |
| ENSE00001685943 | 80335730 | 80335879 |
| ENSE00003513146 | 80583093 | 80583183 |
| ENSE00003585984 | 80869993 | 80870135 |
| ENSE00003672667 | 80362754 | 80362884 |
Expression profiles
Bgee: expression breadth ubiquitous, 157 present calls, max score 96.86.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6459 / max 104.7445, expressed in 158 samples.
Highest expression (Bgee): bronchial epithelial cell, bronchus, sperm, buccal mucosa cell, testis.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CFAP299 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 8 tissues and its splicing (sQTL) in 3 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
11 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Testis | eqtl | 2.8e-62 | -0.55 | 4:80694034:T:C |
| Testis | sqtl | 2.2e-19 | +0.71 | 4:80639834:G:A |
| Brain Cerebellum | eqtl | 3.1e-06 | +1.77 | 4:80286532:G:GAGC |
| Brain Cerebellar Hemisphere | eqtl | 5.7e-06 | +1.47 | 4:80286532:G:GAGC |
| Lung | sqtl | 6.9e-06 | -0.46 | 4:80633422:C:A |
| Cells Cultured fibroblasts | eqtl | 1.8e-05 | +0.84 | 4:80286532:G:GAGC |
| Thyroid | eqtl | 4.8e-04 | +0.27 | 4:80850936:G:T |
| Brain Hippocampus | sqtl | 2.3e-03 | -0.67 | 4:80639834:G:A |
| Nerve Tibial | eqtl | 3.4e-03 | -0.27 | 4:80415641:T:C |
| Esophagus Muscularis | eqtl | 1.4e-02 | -0.22 | 4:80722462:G:T |
| Brain Hippocampus | eqtl | 2.8e-02 | -0.19 | 4:80984870:C:T |
FANTOM5 promoters
1 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 48535 | 0.6459 | 158 |
Top tissues by expression
showing 100 of 254 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 96.86 | gold quality |
| bronchus | UBERON:0002185 | 94.36 | gold quality |
| sperm | CL:0000019 | 93.31 | gold quality |
| buccal mucosa cell | CL:0002336 | 91.30 | silver quality |
| left testis | UBERON:0004533 | 88.82 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 88.60 | gold quality |
| right uterine tube | UBERON:0001302 | 88.58 | gold quality |
| right testis | UBERON:0004534 | 87.98 | gold quality |
| testis | UBERON:0000473 | 86.26 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 82.65 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.43 | gold quality |
| oviduct epithelium | UBERON:0004804 | 79.57 | gold quality |
| fallopian tube | UBERON:0003889 | 75.71 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 75.24 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 73.66 | gold quality |
| adult organism | UBERON:0007023 | 73.52 | gold quality |
| stromal cell of endometrium | CL:0002255 | 68.11 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 67.88 | gold quality |
| corpus callosum | UBERON:0002336 | 65.53 | gold quality |
| right lung | UBERON:0002167 | 64.75 | gold quality |
| sural nerve | UBERON:0015488 | 64.42 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 64.11 | silver quality |
| cerebellar cortex | UBERON:0002129 | 63.58 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 63.43 | gold quality |
| ventricular zone | UBERON:0003053 | 62.29 | gold quality |
| cerebellum | UBERON:0002037 | 61.87 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 61.71 | gold quality |
| caput epididymis | UBERON:0004358 | 61.50 | gold quality |
| left uterine tube | UBERON:0001303 | 59.78 | gold quality |
| hypothalamus | UBERON:0001898 | 57.14 | gold quality |
| oocyte | CL:0000023 | 57.03 | silver quality |
| lower esophagus muscularis layer | UBERON:0035833 | 55.61 | gold quality |
| lower esophagus | UBERON:0013473 | 55.43 | gold quality |
| tibialis anterior | UBERON:0001385 | 55.04 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| granulocyte | CL:0000094 | 54.16 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 54.09 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| Ammon’s horn | UBERON:0001954 | 53.41 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.30 | gold quality |
| mucosa of stomach | UBERON:0001199 | 52.85 | gold quality |
| endocervix | UBERON:0000458 | 52.66 | gold quality |
| deltoid | UBERON:0001476 | 52.56 | gold quality |
| lung | UBERON:0002048 | 52.29 | gold quality |
| calcaneal tendon | UBERON:0003701 | 51.75 | gold quality |
| thyroid gland | UBERON:0002046 | 51.73 | gold quality |
| prefrontal cortex | UBERON:0000451 | 51.57 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 51.00 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 51.00 | gold quality |
| endometrium | UBERON:0001295 | 50.80 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 50.55 | gold quality |
| caudate nucleus | UBERON:0001873 | 50.53 | gold quality |
| upper lobe of lung | UBERON:0008948 | 50.39 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| tibial nerve | UBERON:0001323 | 49.81 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 49.44 | gold quality |
| cerebellar vermis | UBERON:0004720 | 48.93 | gold quality |
| pancreatic ductal cell | CL:0002079 | 48.85 | silver quality |
| kidney | UBERON:0002113 | 48.36 | gold quality |
| frontal cortex | UBERON:0001870 | 48.22 | gold quality |
| tendon | UBERON:0000043 | 48.20 | gold quality |
| ileal mucosa | UBERON:0000331 | 48.05 | silver quality |
| amygdala | UBERON:0001876 | 48.03 | gold quality |
| neocortex | UBERON:0001950 | 47.69 | gold quality |
| quadriceps femoris | UBERON:0001377 | 47.65 | gold quality |
| right frontal lobe | UBERON:0002810 | 47.33 | gold quality |
| gall bladder | UBERON:0002110 | 47.06 | gold quality |
| cerebral cortex | UBERON:0000956 | 46.89 | gold quality |
| brain | UBERON:0000955 | 46.77 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 46.41 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 45.61 | gold quality |
| metanephros | UBERON:0000081 | 45.47 | gold quality |
| vastus lateralis | UBERON:0001379 | 45.40 | gold quality |
| cortex of kidney | UBERON:0001225 | 45.33 | gold quality |
| right ovary | UBERON:0002118 | 45.31 | gold quality |
| metanephros cortex | UBERON:0010533 | 45.07 | gold quality |
| forebrain | UBERON:0001890 | 45.06 | gold quality |
| ovary | UBERON:0000992 | 44.75 | gold quality |
| left ovary | UBERON:0002119 | 44.61 | gold quality |
| muscle tissue | UBERON:0002385 | 44.49 | gold quality |
| temporal lobe | UBERON:0001871 | 44.37 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 43.58 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| primary visual cortex | UBERON:0002436 | 43.52 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 43.49 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 43.39 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 43.26 | gold quality |
| amniotic fluid | UBERON:0000173 | 43.19 | gold quality |
| spinal cord | UBERON:0002240 | 43.13 | gold quality |
| uterine cervix | UBERON:0000002 | 43.04 | gold quality |
| thymus | UBERON:0002370 | 42.92 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 42.72 | gold quality |
| occipital lobe | UBERON:0002021 | 42.58 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| uterus | UBERON:0000995 | 42.56 | gold quality |
| ganglionic eminence | UBERON:0004023 | 42.39 | gold quality |
| lymph node | UBERON:0000029 | 42.09 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-180759 | yes | 5299.01 |
| E-ANND-2 | yes | 3752.20 |
| E-ANND-3 | yes | 10.21 |
| E-MTAB-7381 | no | 67.62 |
HPA expression
RNA tissue specificity: Group enriched
51 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Testis | tissue | 25.6 | high |
| Fallopian tube | tissue | 18.6 | high |
| Choroid plexus | tissue | 6.0 | medium |
| Periaqueductal gray | tissue | 5.7 | |
| Hippocampal formation | tissue | 4.8 | |
| Cerebral cortex | tissue | 3.9 | not detected |
| Occipital cortex | tissue | 3.9 | |
| Somatosensory cortex | tissue | 2.9 | |
| Entorhinal cortex | tissue | 2.6 | |
| Medulla oblongata | tissue | 2.5 | |
| Basal ganglia | tissue | 2.4 | not detected |
| Retrosplenial cortex | tissue | 2.4 | |
| Pons | tissue | 2.3 | |
| Septum | tissue | 2.3 | |
| Temporal cortex | tissue | 2.3 | |
| Substantia nigra | tissue | 2.1 | |
| Amygdala | tissue | 2.0 | |
| Hypothalamus | tissue | 2.0 | |
| Caudate putamen | tissue | 2.0 | |
| Thalamus | tissue | 1.9 | |
| Superior colliculi | tissue | 1.8 | |
| Prefrontal cortex | tissue | 1.7 | |
| Putamen | tissue | 1.6 | |
| Insular cortex | tissue | 1.6 | |
| Motor cortex | tissue | 1.4 | |
| Midbrain | tissue | 1.4 | |
| Retrosplenial and cingulate cortex | tissue | 1.4 | |
| Spinal cord | tissue | 1.2 | |
| Hippocampus | tissue | 1.2 | not detected |
| Ventral forebrain | tissue | 1.2 | |
| Nucleus accumbens | tissue | 1.1 | |
| Corpus callosum | tissue | 1.1 | |
| Frontal cortex | tissue | 1.0 | |
| Lung | tissue | 1.0 | not detected |
| Locus coeruleus | tissue | 0.9 | |
| Cerebellum | tissue | 0.8 | not detected |
| Olfactory bulb | tissue | 0.8 | |
| Retina | tissue | 0.7 | |
| Postcentral gyrus | tissue | 0.7 | |
| Ovary | tissue | 0.5 | not detected |
| Thyroid gland | tissue | 0.5 | not detected |
| Cervix | tissue | 0.4 | not detected |
| Endometrium 1 | tissue | 0.2 | low |
| Kidney | tissue | 0.2 | not detected |
| Pituitary gland | tissue | 0.1 | |
| Lymph node | tissue | 0.1 | not detected |
| Breast | tissue | 0.1 | not detected |
| Gallbladder | tissue | 0.1 | not detected |
| Duodenum | tissue | 0.1 | not detected |
| Thymus | tissue | 0.1 | |
| Nasopharynx | tissue | -1.0 | medium |
Brain sub-regions (HPA Brain Atlas): detected in 170; highest nTPM — Nucleus tractus solitarii (11.9), Periaquaductal grey, lateral (8.0), Cervical spinal cord, central gray (7.9), Periaquaductal grey, dorsal (6.5), Superior vestibular nucleus (5.3).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting CFAP299 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
11 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-576-5P | 99.84 | 70.46 | 2582 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-12124 | 99.68 | 69.17 | 2700 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-4297 | 98.77 | 66.95 | 2013 |
| HSA-MIR-374B-3P | 98.63 | 68.24 | 1360 |
| HSA-MIR-5691 | 98.23 | 67.02 | 1335 |
| HSA-MIR-6805-3P | 98.23 | 67.02 | 1334 |
| HSA-MIR-5088-5P | 97.97 | 64.28 | 487 |
Functional genomics
gnomAD constraint: pLI 0.000975, LOEUF 1.36, missense Z 0.199 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000358105 — one region, missense o/e 1.12.
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cfap299 | ENSDARG00000088753 |
| mus_musculus | Cfap299 | ENSMUSG00000057816 |
| rattus_norvegicus | Cfap299 | ENSRNOG00000067409 |
| drosophila_melanogaster | CG3528 | FBGN0031430 |
| drosophila_melanogaster | CG14013 | FBGN0031720 |
| drosophila_melanogaster | CG14017 | FBGN0031721 |
| drosophila_melanogaster | CG8138 | FBGN0038122 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1916571) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 1 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| increased heart weight | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | Q2YDG2 | 87.1% | Diamond |
| Xenopus laevis | Q5PQ44 | 75.5% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| CFAP299-AS1 | ncRNA | 105377305 |
| FGF5 | protein-coding | 2250 |
| BMP3 | protein-coding | 651 |
| PRKG2-AS2 | ncRNA | 124900726 |
| PRKG2 | protein-coding | 5593 |
| PRKG2-AS1 | ncRNA | 101928942 |
| PRDM8-AS1 | ncRNA | 105377303 |
| PRDM8 | protein-coding | 56978 |
| RASGEF1B | protein-coding | 153020 |
Protein
Protein identifiers
Cilia- and flagella-associated protein 299 — Q6V702 (reviewed: Q6V702)
All UniProt accessions (3): E7EPK2, G5E9Y8, Q6V702
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in spermatogenesis.
Subcellular location. Cytoplasm. Nucleus.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6V702-2 | 2 | yes |
| Q6V702-1 | 1 | |
| Q6V702-3 | 3 |
RefSeq proteins (2): NP_001193926, NP_689983* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027887 | DUF4464 | Family |
Pfam: PF14713
UniProt features (23 total): strand 9, splice variant 3, helix 3, sequence conflict 3, turn 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
2 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 9FGP | cilia and flagella associated protein 299 | X-RAY DIFFRACTION | 1.49 |
| 8J07 | 96nm repeat of human respiratory doublet microtubule and associated axonemal complexes | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6V702-F1 | 87.40 | 0.53 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): cytosol; plasma membrane
Antibody reliability (HPA): IH approved · IF approved
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 50 (showing top):
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, WHN_B, chr4q21, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3, HOXB4_TARGET_GENES, MAFG_TARGET_GENES, PAX3_TARGET_GENES, PAX7_TARGET_GENES, PRDM12_TARGET_GENES, ZNF22_TARGET_GENES, ZNF577_TARGET_GENES, ZNF781_TARGET_GENES, MIR4795_3P, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
4 GO namespaces:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
showing 15 of 1,353 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP299 | CFAP96 | A7E2U8 | 546 |
| CFAP299 | SHISA3 | A0PJX4 | 536 |
| CFAP299 | TMEM33 | P57088 | 530 |
| CFAP299 | CFAP97D2 | A0A1B0GU71 | 523 |
| CFAP299 | ANTXR2 | P58335 | 518 |
| CFAP299 | ACOXL | Q9NUZ1 | 515 |
| CFAP299 | SLC30A9 | Q6PML9 | 512 |
| CFAP299 | C4orf36 | Q96KX1 | 504 |
| CFAP299 | TEX9 | Q8N6V9 | 485 |
| CFAP299 | TMX4 | Q9H1E5 | 471 |
| CFAP299 | CFAP184 | Q2M329 | 464 |
| CFAP299 | CFAP97D1 | B2RV13 | 450 |
| CFAP299 | KAZN | Q674X7 | 415 |
| CFAP299 | SHROOM4 | Q9ULL8 | 411 |
| CFAP299 | MAGEL2 | Q9UJ55 | 410 |
IntAct
Human interaction partners of CFAP299 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
2 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| NFE2L2 | physical association | 0.510 | 3 |
| UBB | association | 0.350 | 1 |
Disease & clinical
Genetic variants
Variant evidence for CFAP299: 15 ClinVar records (0 pathogenic / likely pathogenic); 15 GWAS associations.
ClinVar
15 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 8 |
| Likely benign | 4 |
| Benign | 1 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 29 predictions of 2,222):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 4:80362752–80362753 | acceptor_loss | 1.0000 | 2 |
| 4:80362885–80362886 | donor_loss | 1.0000 | 4 |
| 4:80500311 | donor_gain | 1.0000 | |
| 4:80583091–80583092 | acceptor_loss | 1.0000 | 6 |
| 4:80583184–80583185 | donor_loss | 1.0000 | 5 |
| 4:80869982 | acceptor_gain | 1.0000 | |
| 4:80335880–80335881 | donor_loss | 0.9900 | 5 |
| 4:80362752–80362753 | acceptor_loss | 0.9900 | 3 |
| 4:80362838 | donor_gain | 0.9900 | |
| 4:80474276 | acceptor_gain | 0.9900 |
AlphaMissense
549 missense substitutions predicted likely pathogenic (of 1,536 scored), across 144 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| D157 | 8 | 0.971 | 0.985 |
| D131 | 8 | 0.958 | 0.979 |
| D32 | 8 | 0.948 | 0.966 |
| D193 | 8 | 0.919 | 0.964 |
| F62 | 8 | 0.912 | 0.990 |
| H227 | 8 | 0.907 | 0.964 |
| D226 | 8 | 0.903 | 0.956 |
| F188 | 8 | 0.828 | 0.989 |
| F141 | 8 | 0.823 | 0.958 |
| F115 | 7 | 0.965 | 0.989 |
| F145 | 7 | 0.942 | 0.979 |
| E102 | 7 | 0.938 | 0.977 |
| R135 | 7 | 0.934 | 0.984 |
| W163 | 7 | 0.922 | 0.969 |
| F225 | 7 | 0.910 | 0.972 |
| F17 | 7 | 0.900 | 0.990 |
| F23 | 7 | 0.887 | 0.971 |
| F160 | 7 | 0.856 | 0.983 |
| D38 | 7 | 0.774 | 0.873 |
| D25 | 7 | 0.704 | 0.839 |
HPA cancer prognostics
RNA cancer specificity: Cancer enhanced (Uterine Corpus Endometrial Carcinoma)
Disease associations
OMIM: gene `` | disease phenotypes:
GWAS associations
15 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST90000025_953 | Appendicular lean mass | 1e-22 |
| GCST000394_1 | Diastolic blood pressure | 1e-21 |
| GCST006291_115 | Spherical equivalent or myopia (age of diagnosis) | 6e-21 |
| GCST006988_48 | Blond vs. brown/black hair color | 4e-14 |
| GCST90014268_32 | Cataracts | 3e-12 |
| GCST006976_73 | Macular thickness | 9e-11 |
| GCST006661_203 | Male-pattern baldness | 2e-9 |
| GCST006291_127 | Spherical equivalent or myopia (age of diagnosis) | 3e-8 |
| GCST003075_116 | Cognitive decline rate in late mild cognitive impairment | 5e-7 |
| GCST003075_29 | Cognitive decline rate in late mild cognitive impairment | 8e-7 |
| GCST008596_6 | Opioid overdose severity score | 1e-6 |
| GCST001762_696 | Obesity-related traits | 4e-6 |
| GCST008361_8 | Response to cognitive-behavioural therapy in major depressive disorder | 5e-6 |
| GCST009959_10 | Retinal detachment or retinal break | 5e-6 |
| GCST008596_3 | Opioid overdose severity score | 9e-6 |
EFO canonical traits (from GWAS)
9 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0006336 | diastolic blood pressure |
| EFO:0004620 | vitamin B12 measurement |
| EFO:0007710 | cognitive decline measurement |
| EFO:0004847 | age at onset |
| EFO:0003924 | hair color |
| EFO:0007820 | cognitive behavioural therapy |
| EFO:0010140 | opioid overdose severity measurement |
| EFO:0010698 | retinal break |
| EFO:0004980 | appendicular lean mass |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 2 |
| Tobacco Smoke Pollution | decreases expression, decreases methylation | 2 |
| bisphenol A | affects cotreatment, decreases methylation, increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| MT19c compound | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Lead | affects methylation | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cataract, retinal detachment